Clinical trials in Pisa – page 23

574 clinical trials in Pisa, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Pisa at a glance

574

clinical trials

Research sites4

Quick filters

574 trials in Pisa

Open in trial search

Malignant pleural effusion

Not yet recruiting

A Study of Pressurized Aerosol Chemotherapy with Cisplatin and Doxorubicin for Patients with Fluid Buildup Around the Lungs Caused by Cancer

Registered drugNo placebo

A Study of Pressurized Aerosol Chemotherapy with Cisplatin and Doxorubicin for Patients with Fluid Buildup Around the Lungs Caused by Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cisplatin
Sponsor:Azienda Ospedaliero Universitaria Pisana

Contact Research Centre

Conjunctivitis allergic+1

Not yet recruiting

A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

Registered drugNo placebo

A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Ciclosporin
Sponsor:Laboratoires Thea

Contact Research Centre

Acquired ATTR amyloidosis

Not yet recruiting

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Acoramidis Hydrochloride
Sponsor:Eidos Therapeutics Inc.

Contact Research Centre

Asthma

Not yet recruiting

Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

Registered drug

Study comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy

Registered drug

Italy

Participants:0–17 years
Substances:Salmeterol
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Transitional cell carcinoma

Not yet recruiting

Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

InvestigationalNo placebo

Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Disitamab Vedotin
Sponsor:Seagen Inc.

Contact Research Centre

Systemic lupus erythematosus+1

Not yet recruiting

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:CC-97540
Sponsor:Celgene Corp.

Contact Research Centre

Diabetic foot

Not yet recruiting

Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

InvestigationalNo placebo

Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Aup1602-C
Sponsor:Aurealis Oy

Contact Research Centre

Pancreatic carcinoma metastatic

Not yet recruiting

Study of M9140 for Patients With Advanced Pancreatic Cancer

InvestigationalNo placebo

Study of M9140 for Patients With Advanced Pancreatic Cancer

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Sponsor:Merck Healthcare KGaA

Contact Research Centre

Colorectal cancer

Not yet recruiting

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Fondation Franc.Cancerologie Digestive

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Registered drugNo placebo

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cabozantinib
Sponsor:Fondazione Ricerca Traslazionale

Contact Research Centre

Acute respiratory distress syndrome

Not yet recruiting

Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)

Registered drug

Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Pirfenidone
Sponsor:Ospedale San Raffaele S.r.l.

Contact Research Centre

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational

Study on the Effects of TOUR006 for Adults with Thyroid Eye Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6
Sponsor:Tourmaline Bio Inc.

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 234 cities in Italy

Clinical research in Pisa

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Investigating innovative treatments for cardiac conditions and metabolic disorders, with studies focusing on TTR amyloidosis cardiomyopathy and chronic kidney disease management.

Heart Disease Therapeutics
Kidney Disease Management
Hypertension Control

Current trials evaluate novel compounds for improving patient outcomes in cardiac conditions and renal disorders.

02 Oncology Studies

Comprehensive research into various cancer types, including colorectal cancer, gastric cancer, and lung cancer, testing targeted therapies and innovative treatment combinations.

Metastatic Cancer Treatment
Targeted Therapy Development
Immunotherapy Research

Advanced clinical trials exploring breakthrough treatments for multiple cancer types.

03 Autoimmune & Inflammatory Conditions

Studies focusing on chronic inflammatory conditions including Sjögren's Syndrome, psoriatic arthritis, and hidradenitis suppurativa.

Inflammatory Disease Management
Autoimmune Treatment Innovation
Novel Therapeutic Approaches

Evaluating new therapeutic options for improving quality of life in patients with chronic inflammatory conditions.

04 Respiratory & Infectious Diseases

Research into respiratory conditions and infectious diseases, including studies on chronic rhinosinusitis and respiratory syncytial virus infections.

Respiratory Disease Treatment
Infection Management
Vaccine Development

Investigating new approaches to treat and prevent respiratory infections and related conditions.

Back to Italy All countries